tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alethia Young, 298 are a BUY (83.94%), 55 are a HOLD (15.49%), 2 are a SELL (0.56%).
Analyst Alethia Young, carries an average stock price target met ratio of 60.66% that have a potential upside of 48.83% achieved within 354 days. Previously, Alethia Young worked at CANTOR FITZGERALD, CREDIT SUISSE, DEUTSCHE BANK.
Alethia Young’s has documented 718 price targets and ratings displayed on 60 stocks. The coverage was on Healthcare, Basic Materials, Communication Services, Technology sectors.
Most recent stock forecast was given on STOK, Stoke Therapeutics at 08-Jan-2025.
Analyst best performing recommendations are on CLVS (CLOVIS ONCOLOGY).
The best stock recommendation documented was for BIIB (BIOGEN) at 11/3/2020. The price target of $278 was fulfilled within 1 day with a profit of $30.99 (12.55%) receiving and performance score of 125.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Nov-2019
$11
6 years 10 months 28 days ago
(07-Nov-2019)
0/2 (0%)
$11 (0.00%)
$5
$4.82 (2677.78%)
$5
6 years 11 months 17 days ago
(18-Oct-2019)
0/4 (0%)
$5 (0.00%)
$2.5
$2.32 (1288.89%)
$8
7 years 5 months 2 days ago
(03-May-2019)
0/2 (0%)
$2.5 (0.00%)
$3.5
$3.32 (1844.44%)
$4
8 years 7 months 27 days ago
(08-Feb-2018)
0/4 (0%)
$3.5 (0.00%)
$650
$649.82 (361011.12%)
$16
9 years 23 days ago
(12-Sep-2017)
0/2 (0%)
$650 (0.00%)
